gptkbp:instanceOf
|
gptkb:Company
|
gptkbp:acquisition
|
gptkb:Hexal_AG
Novartis AG
|
gptkbp:awards
|
various industry recognitions
|
gptkbp:CEO
|
Richard_Francis
|
gptkbp:competitors
|
gptkb:GSK
gptkb:Johnson_&_Johnson
gptkb:Mylan
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Teva_Pharmaceuticals
gptkb:Roche
gptkb:Amgen
Sanofi
AbbVie
|
gptkbp:employees
|
over 10,000
|
gptkbp:focus
|
biosimilars
|
gptkbp:founded
|
1886
|
gptkbp:headquarters
|
gptkb:Holzkirchen,_Germany
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sandoz Division
|
gptkbp:industry
|
pharmaceuticals
|
gptkbp:market
|
over 160 countries
|
gptkbp:operatesIn
|
global market
|
gptkbp:partnerships
|
various healthcare organizations
|
gptkbp:partOf
|
Novartis
|
gptkbp:productLine
|
diabetes
oncology
antibiotics
central nervous system
hormones
dermatology
pain management
gastroenterology
cardiovascular
respiratory
|
gptkbp:products
|
generic drugs
|
gptkbp:researchAndDevelopment
|
biotechnology
|
gptkbp:revenue
|
$10 billion (2020)
|
gptkbp:subsidiary
|
Novartis
|
gptkbp:sustainabilityInitiatives
|
community engagement
ethical sourcing
employee welfare
environmental responsibility
access to medicine
|
gptkbp:website
|
www.sandoz.com
|